Science DailyTiming is everything to build kidneys from scratchScience DailySo it is for stem cells building kidney tissue discovered timing is critical as the precise arrival of progenitor cells dictates their form and function in the kidney. The find… Continue reading
Forbes |
‘I have definitely hit the jackpot.’ Advanced breast cancer disappears after new immunotherapy
Los Angeles Times In the all-hands effort to harness the powers of the immune system to fight cancer, scientists have reported a new approach that eliminated all evidence of advanced-stage breast cancer in a 49-year-old woman who had run out of treatment options. New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast CancerForbes Novel Immunotherapy Method Led to Complete Regression of Breast Cancer in PatientWall Street Journal New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatmentsScience Daily CBS News –Voice of America –New England Journal of Medicine all 367 news articles » |
Motley Fool |
Could Celgene Shake Up the CAR–T Market?
Motley Fool The current CAR-T party of two might have a couple of new companions on the way. And those new entrants could bring some excitement to the party. Only two chimeric antigen T–cell receptor (CAR-T) therapies are currently approved by the FDA — Novartis’ … Celgene Presents Data on CAR T Therapy, Revlimid & PomalystNasdaq bluebird shares recover after slump following ASCO CAR–T data presentationMedCity News Celgene (CELG), bluebird bio (BLUE) Phase I Study of bb2121 Demonstrates Deep and Durable Responses at ASCOStreetInsider.com |